Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Neola Medical via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Kontakt
Språk
Typ
Språk
Typ
2025-02-25 07:10:00
“A Major Milestone” – CEO Hanna Sjöström in interview with Life Science Sweden
Neola Medical takes an important step forward in advancing neonatal care. After years of development, the company has received approval to initiate its first clinical study on preterm born babies—a key step in evaluating its continiuos lung monitoring device, Neola®, for this vulnerable patient group. In an interview with Life Science Sweden, CEO Hanna Sjöström discusses the significance of t...
2025-02-14 07:10:00
Redeye Interview with CEO Hanna Sjöström
Following the release of Neola Medical’s Q4 2024 report, Redeye Equity Research Analyst Gustaf Meyer interviewed CEO Hanna Sjöström to discuss key takeaways, the company’s progress toward the clinical phase, and the upcoming first clinical study on preterm born babies in Sweden
2025-02-13 10:38:00
Did you miss Neola Medical’s Q4 report presentation?
Catch up on key insights into Neola Medical’s latest developments as we prepare for clinical studies and continue strengthening our presence in the U.S. market
2024-12-16 12:34:15
Highlighting Another Key Milestone: Achieving CB Certification for Neola®
As we continue reflecting on 2024, we’re pleased to share another significant achievement—obtaining CB certification for our lung monitoring device, Neola®. This certification confirms that Neola® meets specific quality requirements and international standards for medical devices in healthcare, with particularly high demands on safety, essential performance, and electromagnetic compatibility...
2024-12-10 12:10:19
Highlighting a Key Milestone: Human Factors Validation Study in the U.S
As the year draws to a close, we are proud to highlight one of our key milestones of 2024—the successful completion of the Human Factors Validation Study for our lung monitoring device, Neola®. The study was conducted in Boston, USA, to validate the usability of the medical device Neola®, and demonstrate that it is safe for its intended use by healthcare professionals in neonatal intensive car...
2024-12-05 12:47:21
Highlights from Neola Medical’s Presentation at Redeye Technology & Life Science Day
Earlier this week, Neola Medical participated in the Redeye Technology and Life Science Day in Stockholm, showcasing the company’s significant progress and outlining its future plans during an engaging presentation and dynamic Q&A session. Discover deeper insights into Neola Medical’s strategy, clinical advancements, and vision for the future by watching the session here
2024-12-02 11:49:55
Final part of our exclusive lecture series on GASMAS technology with Professor Vineet Bhandari
In the final part of our video series, Professor Vineet Bhandari examines the limitations of current standard of care for neonatal respiratory monitoring and how the advanced potential of the Neola® device could transform neonatal care for preterm born infants. Watch Part 3 here: Lecture "GASMAS Transit to the NICU – Are We There Yet?” by Professor Bhandari – Part 3 Discover how GASMAS coul...
2024-11-29 11:43:11
Scaling New Heights: Proud Graduates of 10xHealth Scaleup Program 2024
We are proud and honored to be graduates of the 10xHealth life science scale-up program, a transformative initiative for accelerated growth developed by SmiLe Venture Hub in close collaboration with Medicon Village Innovation and partially funded by the European Regional Development Fund. Over the course of nearly a year, this program has provided us with invaluable tools, insights, and strategies...
2024-11-29 10:59:34
Neola Medical’s Board Member Monica Alfaro Welling Honored with the NOME Mentor Award 2024
We are thrilled to share that Monica Alfaro Welling, a valued member of Neola Medical’s board of directors, has been awarded the prestigious NOME Mentor Award 2024 at this year’s NOME Annual Meeting and Startup Competition in Copenhagen, held on November 28. The award recognizes Monica Alfaro Welling’s exceptional dedication and impactful mentorship to startups in the life science sector. He...
2024-11-27 10:29:10
Neola Medical's presentation at Stora Aktiedagarna in Stockholm
Yesterday CEO Hanna Sjöström showcased Neola Medical’s vision and strategic advancements during the presentation at Stora Aktiedagarna in Stockholm, highlighting the future of neonatal care. The presentation was met with great interest, filling the room with engaged attendees, exploring our mission and hearing about our progress toward market approval in the U.S. Join our journey and gain more...
2024-11-25 10:15:38
Part 2 of our exclusive lecture series on GASMAS technology with Professor Vineet Bhandari
In Part 2 of our lecture series, Professor Vineet Bhandari discusses the NIOMI study, where Neola® in a research version has been used in clinical settings generating real-world evidence. Watch Part 2 here: Lecture "GASMAS Transit to the NICU – Are We There Yet?” by Professor Bhandari – Part 2 Discover how GASMAS could revolutionize neonatal care, providing safer, non-invasive methods for m...
2024-11-22 13:28:05
Neola Medical’s exclusive participation at Pediatric MedTech CEO Summit in New York
Photo: Welcome speech to all selected Stanford Impact1 companies at the Pediatric MedTech CEO Summit by Dr. Janene H. Fuerch, Co-Director of Impact1, MD, and Assistant Professor of Neonatology at Stanford University Medical Center CEO Hanna Sjöström had the privilege of representing Neola Medical at this year’s Pediatric MedTech CEO Summit, a highly regarded forum established by the prestigiou...
2024-11-18 14:55:20
World Prematurity Day
Yesterday, on World Prematurity Day, we honored the smallest yet most inspiring fighters among us—preterm born babies—and paid tribute to the unwavering dedication of parents, caregivers, and medical teams who stand by their side every step of the way. At Neola Medical, we are deeply committed to transforming the future for our most vulnarable patients. With our groundbreaking device, Neola®,...
2024-11-18 10:02:07
First part of our exclusive lecture series on GASMAS technology with Professor Vineet Bhandari
We’re thrilled to release the first part of our exclusive lecture series with renowned U.S. neonatologist Professor Vineet Bhandari. In this segment, Professor Bhandari introduces the groundbreaking concept behind GASMAS technology. Watch Part 1 here: Lecture "GASMAS Transit to the NICU – Are We There Yet?” by Professor Bhandari – Part 1 Discover how GASMAS could revolutionize neonatal car...
2024-11-15 12:56:12
Neola Medical hosts The BioStock Life Science Summit 2024
CEO Hanna Sjöström joins the expert panel "Medtech – A Hidden Gem?" at The BioStock Life Science Summit 2024 on November 20 at 16:30 CET (16.30), where she and fellow industry experts discuss key topics such as how to build, fund, and protect a strong medtech enterprise. The event is packed with company showcases and thought-provoking insights from industry leaders as well as expert investors....
2024-11-15 09:52:53
Neola Medical: Key Milestones & Future Plans at Redeye Medtech & Diagnostics Event 2024
Did you miss CEO Hanna Sjöström's investor presentation at the Redeye Theme: Medtech & Diagnostics Event 2024? Don’t worry—you can still catch up on all the exciting updates! In her presentation, CEO Hanna Sjöström highlighted Neola Medical’s significant progress over the past year, including major milestones toward U.S. market approval. The company is now entering a critical clinical va...
2024-11-11 12:49:03
U.S. professor in neonatology presents lecture on GASMAS technology at international Neonatal Medicine Congress
Photo: Professor Christian Speer, CEO Hanna Sjöström, CTO Sara Bergsten, Professor Christoph Härtel and Director QA & RA Magnus Johnsson Neola Medical was honored to have the esteemed U.S. Professor Vineet Bhandari, Division Head in Neonatology at The Children’s Regional Hospital at Cooper, Camden, USA, present a highly keynote lecture on its GASMAS technology, titled “GASMAS Transit to the...
2024-11-08 12:00:10
The Q3 2024 report commentary with Redeye
Did you miss the Redeye interview with CEO Hanna Sjöström following the release of the Q3 2024 report? Watch the interview below
2024-11-06 11:27:23
The Q3 report presentation of 2024!
Watch when CEO Hanna Sjöström and CFO David Folkesson presented Neola Medical’s Q3-report of 2024. Learn more about the company’s financial position and the progress from this quarter, toward market approval in the U.S. After the presentation a brief Q&A follows. ✨ The presentation is recorded and can be seen here: https://youtu.be/JCWPbqBFqQQ
2024-10-28 11:55:18
Redeye initiates coverage of Neola Medical: Meeting an unmet need in neonatal care
Redeye initiates coverage of Neola Medical with a fair value estimate of SEK 3.1 per share in the base case scenario and SEK 5.8 per share in the bull case scenario. Read the entire coverage report by Redeye here: Redeye coverage report of Neola Medical
2024-10-22 11:53:56
Neola Medical hosting Science for Breakfast at Medicon Village
CEO Hanna Sjöström had the pleasure of sharing Neola Medical’s inspiring journey—from groundbreaking research at Lund University, to becoming a startup at Medicon Village, to scaling up as a NOME graduate. A huge thank you to Medicon Village and the Nordic Mentor Network for Entrepreneurship (NOME) for organizing this fantastic event! We’re proud to contribute to such a vibrant community, ...
2024-10-21 11:48:32
Key Leader at SEB: Moved by the Heart of Medtech Innovation
When SEB's Co-Head of Retail Banking, Mika Burman Götz, visited Neola Medical’s headquarters in Lund, she was not only surrounded by innovation and cutting-edge research but also witnessed a vision for the future of modern healthcare—where technological advancements touch the very essence of human life. "Neola Medical’s product truly goes straight to the heart, standing as a remarkable exam...
2024-09-25 08:09:56
Neola Medical’s First American Board Member: A Key to Global Expansion
Neola Medical's expansion in the U.S. market is gaining momentum, with significant progress in launch preparations. As part of the company’s strategy to leverage U.S. market expertise, Neola Medical has appointed Monica Alfaro Welling as its first American board member. With over 30 years of leadership experience in the biopharma and MedTech sectors across global markets, Monica brings invaluabl...
2024-08-28 10:00:27
BioStock interview with new CFO at Neola Medical
Neola Medical has strengthened its management team, adding David Folkesson as the new CFO. He joins at an important stage for the company, which is currently preparing for clinical validation of Neola®. BioStock has contacted David to find out more about his background and how he sees the journey that currently lies ahead. Read the entire article by BioStock here
2024-08-26 12:00:51
New BioStock interview with CEO Hanna Sjöström
"This is a step towards optimizing the conditions for a successful clinical study on preterm born infants in the U.S.", says CEO anna Sjöström After recently obtaining the CB certificate for its medical device, Neola Medical is now intensively preparing for clinic. As part of these efforts, the company plans to conduct a clinical pilot study in collaboration with a neonatal unit in Sweden. Read ...
2024-08-23 11:00:03
CEO Hanna Sjöström visits Västra Hamnen Möter
The company's product for continuous lung monitoring of preterm born infants is attracting significant international interest. Watch CEO Hanna Sjöström and CEO Oscar Ahlgren at Västra Hamnen TV discuss Neola Medical’s promising study data, the substantial medical need, and what remains to be done before submitting a regulatory application to the FDA. https://youtu.be/-d9AjltFsL8?si=6TJzbnLmfZ...
2024-08-16 11:02:46
Q2 report commentary in the BioStock studio - The acquisition of the CB certification bolstered Neola Medical's Q2
The second quarter of 2024 marked several milestones towards achieving market approval in the U.S. Notably, the company's medical device received CB certification, indicating that Neola®meets the required technical safety standards. Clinical trials are now on the horizon, with further updates expected in the fall. Watch CEO Hanna Sjöström and CTO Sara Bergsten discuss Neola Medical's newly rele...
2024-08-15 14:32:12
The Q2 report presentation of 2024!
Did you miss all the exciting updates when CEO Hanna Sjöström and CFO Christian Gyllenberg presented Neola Medical’s Q2-report of 2024 at Finwire TV? Learn more about the company’s financial position and the important key achievements from this quarter, aimed at market approval by the FDA. After the presentation a brief Q&A follows. The presentation is recorded and can be seen here: https://...
2024-08-06 08:01:30
Clinical potential in neonatal respiratory monitoring with Neola®’s GASMAS technology
Discover how the breakthrough patented technology in Neola®, biomedical GASMAS, a unique method grounded in laser spectroscopy for observing the lung volume and the free oxygen gas concentration inside of the lung in real-time, aim to improve neonatal respiratory monitoring. A detailed commentary on the review article, “Gas in Scattering Media Absorption Spectroscopy (GASMAS) as a potential too...
2024-07-02 08:51:31
Chefakademin invites CEO Hanna Sjöström in an exclusive interview
Hanna Sjöström's career trajectory is impressive: first an international top career at Coca-Cola and L’Oréal, now CEO of a life-saving startup. Chefakademin's Executive MBA is part of the recipe for success. "We developed the American launch strategy for Neola Medical during the course. It was absolutely invaluable. It was like having my own little McKinsey team," says CEO Hanna Sjöström. L...
2024-06-19 09:07:42
Lund University Master Thesis on expanding Neola Medical's technology to more patient groups
With the aim of taking Neola Medical’s cutting-edge lung monitoring for preterm born infants to larger patients such as children and adults, a Master Thesis at Lund University Div. of Combustion Physics by Henrik Palme, delves into the opportunity for advanced lung monitoring with High Powered GASMAS. This research highlights the potential to upgrade respiratory care and continuous, non-invasive...
2024-06-04 07:46:08
Neola® obtains CB certification and meets partial regulatory requirements for market approval in the USA
Press communication Lund, Sweden, June 4, 2024 This is a translation of the Swedish press release published 2024-06-04 Neola Medical AB (publ) announced today that Neola®, the company's medical device for continuous monitoring of the lungs of preterm born infants, has successfully passed the comprehensive and stringent testing against IEC 60601-1 and IEC 60601-1-2 standards. This has resulted in ...
2024-05-31 10:49:02
New CFO at Neola Medical ahead of market launch in the U.S.
Press communication Lund, Sweden, May 31, 2024 This is a translation of the Swedish press release published 2024-05-31 Neola Medical AB (publ) is pleased to announce the appointment of David Folkesson as Chief Financial Officer, effective August 26, 2024. David Folkesson brings extensive experience as a CFO in both public and private companies. He has previously worked as an auditor at Deloitte an...
2024-05-24 13:08:23
Strong attendance at successful Annual General Meeting 2024
At Wednesday, May 22, a successful Annual General Meeting was held at Neola Medical’s premises, where attending shareholders expressed great satisfaction with the event and the structured meeting. The attendance amongst shareholders was high, and votes represented more than 62% of the company’s shares. CEO Hanna Sjöström’s speech received particularly high praise for its clarity and inspir...
2024-05-22 17:34:10
Neola Medical Publishes Communiqué from the Annual General Meeting 2024
The Annual General Meeting of Neola Medical was held today, May 22, 2024, at the Company's premises at Ideon Gateway, Scheelevägen 27, Lund. Read the decisions from the board of directors in the full press release here: Kommuniké från årsstämma i Neola Medical AB den 22 maj 2024
2024-05-22 13:22:56
BioStock - Successful Human Factors Validation Study by Neola Medical
The major highlight of the Q1 report concerns the usability study conducted in Boston. The objective was to verify the safety of the equipment used to monitor the lungs of preterm born infants and to assess how the neonatal nurses utilized it. Watch CEO Hanna Sjöström and Magnus Johnsson, Head of Quality, discuss the results, the company's financials, and the next steps towards clinical trials i...
2024-05-22 07:51:39
Neola Medical Q1 Report 2024 – Successful Study in the USA Ahead of Regulatory Approval for Neola®
Press communication Lund, Sweden, May 22, 2024 This is a translation of the Swedish press release published 2024-05-22 The first quarter of 2024 commenced with a strengthened cash position following a strong finish to last year, which included a directed share issue at a premium to the share price, several achieved milestones, and successful results from an independent clinical study of Neola® in...
2024-05-17 10:11:10
SwedenBio raises the importance of board competence within the Life Science industry at Annual Meeting in Stockholm
In the photo: CEO Hanna Sjöström, Ulrika Ringdahl COO, Deputy CEO SMiLe Incubator and Ebba Fåhreus, CEO SmiLe Incubator On May 14th, the SwedenBio Annual Meeting and CEO Summit 2024, a pivotal gathering for life science industry leaders, was held at Münchenbryggeriet in Stockholm. CEO Hanna Sjöström attended SwedenBIO's Executive Dinner, which centered on cultivating competent boards. The ev...
2024-05-14 10:49:12
Cardeon's entire shareholding in Neola Medical acquired by major shareholders
Press communication Lund, Sweden, May 14, 2024 This is a translation of the Swedish press release published 2024-05-14 Neola Medical AB (publ) announced today that Cardeon AB's entire 2,358,805 shares in Neola Medical have been acquired by the company's existing major shareholders ANMIRO AB, Conspargo Capital (Pär Josefsson), LMK, Brodvik AB, and Bengt Nevsten, as well as by new shareholder Danie...
2024-04-23 08:50:13
CEO Hanna Sjöström Chairman for MedTech in SwedenBio’s new expert network
"When political processes take time, we are the catalyst that makes things happen." - SwedenBio is forming a new expert network to develop the MedTech industry in Sweden, which has long faced challenges with political and bureaucratic processes that impeding advancement and the integration of Swedish medical innovations into the country's healthcare system. CEO Hanna Sjöström has been appointed ...
2024-04-22 15:12:12
New interview by BioStock about the Human Factors Validation study with Neola® in the USA
Neola Medical’s lung monitoring is user-friendly and safe. These are the results of the usability study cunducted during the spring. “Successful study results are of great importance as we will use them as part of our upcoming FDA application for market approval in the US.”, says Neola CEO Hanna Sjöström. Read the entire article by BioStock here
2024-04-18 09:57:22
Successful results in completed Human Factors Validation Study with Neola® in the USA
Press communication Lund, Sweden, April 18, 2024 This is a translation of the Swedish press release published 2024-04-18 Neola Medical AB (publ) has completed the Human Factors Validation Study with Neola®, the company's medical device for continuous lung monitoring of preterm born infants, in March 2024. The study was conducted in Boston, USA, to validate the usability of the medical device Neol...
2024-04-11 15:16:23
Notice to the Annual general meeting of Neola Medical AB
️Press communication Lund, Sweden, April 10, 2024 Read the entire press release here: Press release - KALLELSE TILL ÅRSSTÄMMA I NEOLA MEDICAL AB For further information, contact: Hanna Sjöström, CEO Neola Medical, phone: +46 (0)760-10 71 16, e-mail: hanna.sjostrom@neolamedical.com Neola Medical AB (publ) develops medical technology device for continuous monitoring of preterm born infants’ ...
2024-04-09 09:14:37
Neola Medical AB publishes Annual report 2023
Press communication Lund, Sweden, April 9, 2024 This is a translation of the Swedish press release published 2024-04-09 Neola Medical AB (publ) announces that the Annual report of 2023 now is available at the company's website, and attached to the press release. Read the press release and the Annual report of 2023 (in Swedish) here: Press release with Annual report 2023 For further information, co...
2024-03-28 08:27:07
Neola® wins silver medal and 25 000 USD in Stanford Pediatric Device Consortium (PDC) Accelerator Pitch Competition 2024
Press communication Lund, Sweden, March 28, 2024 This is a translation of the Swedish press release published 2024-03-28 Neola Medical's product for lung monitoring of preterm born infants, Neola®, was selected by Stanford as one of the top ten most promising medical technology products in the world that can improve care for children. On Friday, March 22, 2024, Neola Medical, as one of the finali...
2024-03-22 12:23:16
Rapidus invites CEO Hanna Sjöström in new podcast Lejonkulan
"With great potential for the youngest" – reads the title as CEO Hanna Sjöström joins venture capitalist Jan Dahlqvist in this week's Lejonkulan, the new podcast of Rapidus, which for the first time hosts a listed company. Listen to the entire episode at Spotify here: Spotify - Lejonkulan Listen to the entire episode at Apple Podcaster here: Apple Podcaster - Lejonkulan
2024-03-20 09:28:33
Neola Medical's CEO shares more about the latest news in the spring investor letter
Press communication Lund, Sweden, March 20, 2024 This is a translation of the Swedish press release published 2024-03-20 The initial months of 2024 continue with intensive work and positive progress for Neola Medical in preparation for upcoming studies for market approval and the launch of Neola® in the USA. The human factors validation study with Neola® has commenced as planned in the USA, and ...
2024-03-14 12:10:20
CEO Hanna Sjöström visits a neonatal intensive care unit in the USA
CEO Hanna Sjöström continues her work of establishing international contacts with key opinion leaders and expanding the company's network as part of the preparatory work for the launch of Neola® in the USA. Recently, CEO Hanna Sjöström visited the neonatal intensive care unit (NICU) at Lucile Packard Children’s Hospital Stanford in Palo Alto, and we conducted a brief interview with her to l...
Visa fler
